Advanced search
Publication Cover
Pathology Volume 33, 2001 - Issue 1
Submit an article Journal homepage
13
Views
2
CrossRef citations to date
0
Altmetric
Research Article

MULTICENTRE STUDY OF THE IN VITRO ACTIVITY OF CEFEPIME, A BROAD-SPECTRUM CEPHALOSPORIN, COMPARED TO OTHER BROAD-SPECTRUM AGENTS

Jan M. Bell, John D. Turnidge, The Cefepime Study Group Women's and Children's Hospital, Adelaide, South Australia
Pages 53-60 | Published online: 06 Jul 2009

  • Wynd MA, Paladino J. Cefepime: a fourth generation parenteral cephalosporin. Ann Pharmacother 1996; 30: 1414-24.
  • Kessler RE, Bies M, Buck RE, Chisholm DR, Puisiano TA, Tsai YA, et al. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum ß-lactam antibiotics. Antimicrob Agents Chemother 1985; 27: 207-16.
  • Bodey G, Ho DS, LeBlanc B. In vitro studies of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 1985; 27: 265-9.
  • Tsuji A, Maniatis A, Bertram MA, Young LS. In vitro activity of BMY-28142 in comparison with those of other ß-lactam antimicrobial agents. Antimicrob Agents Chemother 1985; 27: 515-9.
  • Barbhaiya RH, Forgue ST, Gleason CR, Knupp CA, Pittman KA, Weidler DJ, et al Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses. Antimicrob Agents Chemother 1990; 34: 1118-22.
  • Cronqvist J, Nilsson-Ehlr I, Öqvist B, Norrby SR. Pharmacokinetics of cefepime dihydrochloride arginine in subjects with renal impairment. Antimicrob Agents Chemother 1992; 36: 2676-80.
  • National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement. M100-S9. National Committee for Clinical Laboratory Standards, 1999; Wayne, PA.
  • Jones RN, Thornsberry C, Barry AL, Ayers L, Brown S, Daniel J, et al. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth generation cephalosporin, in clinical microbiology laboratories. J Clin Microbiol 1994; 20: 409-12.
  • Sader HS, Mimica I, Rossi F, Zoccoli C, Montelli AC, Sampaio JL, et al. Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest. Diagn Microbiol Infect Dis 1997; 28: 87-92.
  • Jones RN, Pfaller MA, Marshall SA, Hollis RJ, Wilke WW. Antimicrobial acitivty of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence or resistance, molecular epidemiology, and screening for metallo-enzymes. Diagn Microbiol Infect Dis 1997; 29: 187-92.
  • Jones RN, Salazar JC, Pfaller MA, Doern GV. Multicenter evaulation of antimicrobial resistance to six broad-spectrum ß-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1997; 29: 265-72.
  • Pfaller MA, Jones RN, Doern GV. Multicenter evaulation of the antimicrobial activity of six broad-spectrum ß-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1998; 30: 45-52.
  • Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ. Antimicrobial activity and spectrum investigation of eight broad-spectrum ß-lactam drugs: a 1997 surveillance trial in 102 medical centers in the Unites States. Cefepime Study Group. Diagn Microbiol Infect Dis 1998; 30: 215-28.
  • Sofianou, Tsoulfa S, Kontodimou L, Polydorou F, Malaka E. Comparative activity of cefepime against nosocomial isolates. J Chemother 1997; 9: 341-6.
  • Pierard D, Emmerechts K, Lauwers S. Comparative in vitro activity of cefpirome against isolates from intensive care and haematology/ oncology units. Belgian Multicentre Study Group. J Antimicrob Chemother 1998: 41: 443-50.
  • Hibbert-Rogers LCF, Heritage J, Gascoyne-Binzi DM, Hawkey PM, Todd N, Lewis IJ, et al. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother 1995; 36: 65-82.
  • Lyon DJ, Scheel O, Adeyemi-Doro FA, Ling TK, Cheng AF, Norrby SR. Antimicrobial susceptibility and extended-spectrum beta-lactamases of Hong Kong isolates of Enterobacteriaceae. Scand J Infect Dis 1996; 101: 17-20.
  • Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Goudron P, Sanders CC. Plasmid-mediated resistance to extended-spectrum cephalosporins among Enterobacter aerogenes strains. Antimicrob Agents Chemother 1998; 42: 596-600.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.